Our Customer Charles River Discovery is recruiting Manager / Senior Manager, Oncology to set up and lead their oncology research team in Kuopio, Finland.
Read from below how Charles River describes this interesting role.
For over 75 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.
We are expanding our operations and therefore, we are now looking for a Manager / Senior Manager, Oncology to strengthen our drug development services. In this senior position, you will manage the planning and execution of our new therapy adaption project. You will be ensuring that all project related activities are performed in accordance with our policies, contractual agreements, quality standards, health and safety requirements, financial targets as well as schedule commitments.
This role requires both strong people leader experience and efficient establishment and project management skills. You master high-level design, management, and execution of multiple parallel projects to drive preclinical service program development. The position is permanent and full-time. Please note that this role requires your presence in Kuopio.
What you should bring with you:
MSc/PhD in Life Sciences or equivalent degree
Proven, vast track record of similar role(s) in the field of oncology and/or pharmacology
Clear and efficient communication skills in both English and Finnish
Strong attention to detail, ensuring accuracy and quality in deliverables
Capability to develop work practices and to take lessons learned and implement them into the processes
Ability to work under pressure to deliver the projects with time, cost, and quality
Analytical and problem-solving mindset, with the ability to identify and mitigate risks and challenges
Ability to adapt to changing priorities and work under tight deadlines and excellent collaboration and work multinational team
We offer you:
Working at Charles River means working in a dynamic international organization where we are making the difference. We offer you exciting projects, growth opportunities, meaningful work, inclusive and supportive team. We also support your wellbeing by offering you e.g., wide occupational healthcare, leisure accident insurance and ePassi flex- benefit. We also have an active recreational committee which organizes activities from charity occasions to fun team events.
Applications and more info:
Please send your application with CV by 20th October to our recruitment system. Please note that email applications are not taken into account.
Päivi Meltan (+358 50 351 8855) is the recruitment consultant taking care of this recruitment at Satafarma & Greige Oy and she is happy to give more information about the role. You will reach Päivi on 10th Oct 15.00- 17.00 or on 15th Oct 11.00-12.00
About Discovery Discovery from Charles River is industry-proven in the successful development of novel therapies, with over 320 patents and 74 preclinical drug candidates delivered to our sponsors in the past 17 years. Backed by more than 650 scientists, our comprehensive, integrated portfolio employs the latest technology and platforms to provide chemistry, biology, and pharmacology services that support clients from the earliest stages of hit identification all the way through to IND. Our client-focused, collaborative approach creates true partnerships that anticipate challenges, overcome obstacles, and move us forward together on the journey of getting new drugs to market.
About Charles River Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 22,000 employees within 100 facilities in 26 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world.
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of 86% of the drugs approved by the FDA in 2021.
Agilent inspires and supports discoveries that advance the quality of life. We provide life science, diagnostic and applied market laboratories worldwide with instruments, services, consumables, applications and expertise. Agilent enables customers to gain the answers and insights they seek –– so they can do what they do best: improve the world around us. Information about Agilent is available at www.agilent.com.
Do you have experience with technologies and applications in Genomics, Pathology and Cell Biology and are you looking to further develop your career? Then you might be the person we are looking for!
Agilent Technologies are currently looking for a driven and motivated team player to join as a HDX (Human Diagnostics) Market Specialist for Regions: Denmark/Sweden/ Norway/ Finland
As a Market Specialist , you will be a part of an European Team of Market Specialists, which is closely embedded into the European DGG sales structure. In this critical role, you will apply your expertise and knowledge of the DX market to work with healthcare diagnostic accounts, supporting the sales team in your region, doing Business Development by promoting new applications, uncovering emerging applications in the field of HDx, identifying new customer groups and closely interact with the Marketing and the Business Units of Agilent.
Your primary responsibilities are our suite of genomics and pathology products, instruments and software solutions for immunohistochemistry, molecular pathology and human genetics. Your goal is to proactively develop and implement a successful strategy together with your colleagues from the sales and support teams , to help the organization in exceeding quota and develop new opportunities and strategies for the coming years.
Specifically, this means:
Develop effective strategies and tactics to grow new business
Effectively prospect to find new opportunities in existing and new accounts
Leverage deep knowledge of strategic focus area to develop compelling value proposition
Recognize trends that impact buying of Agilent products
Provide front-line support to HDx Account Managers with persuasion activities
Partner with Account Managers to assist with seminars and negotiations
Qualifications
Bachelor or Master degree or University degree in Biology/Biochemistry/Chemistry (or related)
4+ years practical experience in a relevant environment
Excellent communication skills in Danish or Swedish and English (written and verbal)
You’ve established a proven track record and you are looking for new challenges in the health care diagnostic field to make a real difference and impact the field.
We offer:
A commitment to work/life balance
Total Compensation Package including company car and retirement programs.
Training and development opportunities
An enthusiastic team
A company with values around innovation and contribution, uncompromising integrity, trust, respect and teamwork, speed, focus, and accountability
The diversity of cultural and individual perspectives held by our employees and their commitment to inclusion
Should you have any questions regarding the application process, please contact the recruiter on Natalie.gesler@agilent.com
Agilent Technologies Inc. is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability or any other protected categories under all applicable laws.
For over 75 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.
IMPORTANT: In order to be considered for this position, a resume/CV must be uploaded and submitted during the application process. Please make sure work history and education are added correctly.
Join our team and make the difference!
We are expanding our operations and therefore, we are now looking for a Research Leader to strengthen our drug development services. In this senior position, you will manage the planning and execution of our new therapy adaption project. You will be ensuring that all project related activities are performed in accordance with our policies, contractual agreements, quality standards, health and safety requirements, financial targets as well as schedule commitments. This role requires both strong people leader experience and efficient establishment and project management skills. You master high-level design, management, and execution of multiple parallel projects to drive preclinical service program development. The position is permanent and full-time.
What You Should Bring With You
MSc/PhD in Life Sciences or equivalent degree
Proven, vast track record of similar role(s) in the field of oncology and/or pharmacology
Clear and efficient communication skills in both English and Finnish
Strong attention to detail, ensuring accuracy and quality in deliverables
Capability to develop work practices and to take lessons learned and implement them into the processes
Ability to work under pressure to deliver the projects with time, cost, and quality
Analytical and problem-solving mindset, with the ability to identify and mitigate risks and challenges
Ability to adapt to changing priorities and work under tight deadlines and excellent collaboration and work multinational team
What We Offer You
Working at Charles River means working in a dynamic international organization where we are making the difference. We offer you exciting projects, growth opportunities, meaningful work, inclusive and supportive team. We also support your wellbeing by offering you e.g., wide occupational healthcare, leisure accident insurance and ePassi flex- benefit. We also have an active recreational committee which organizes activities from charity occasions to fun team events.
More info: Associate Director Laboratory Sciences, Tuulia Huhtala (+358504366373) available on Wednesday 11th of September between 15-16 and on Friday 27th of September between 9-10. (UTC+2)
Apply at the latest by 29th of September, we may start interviewing candidates already during the application period.
”When you approach each moment knowing your work helps improve the health and lives of millions worldwide – suddenly everything seems possible. At Charles River, this is the passion that drives us. Join us today and start imagining tomorrow.”
About Discovery
Discovery from Charles River is industry-proven in the successful development of novel therapies, with over 320 patents and 74 preclinical drug candidates delivered to our sponsors in the past 17 years. Backed by more than 650 scientists, our comprehensive, integrated portfolio employs the latest technology and platforms to provide chemistry, biology, and pharmacology services that support clients from the earliest stages of hit identification all the way through to IND. Our client-focused, collaborative approach creates true partnerships that anticipate challenges, overcome obstacles, and move us forward together on the journey of getting new drugs to market.
About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 22,000 employees within 100 facilities in 26 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world.
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of 86% of the drugs approved by the FDA in 2021.
For more information, please visit www.criver.com.
The University of Oulu is a multidisciplinary, international research university, with about 3,600 employees who produce new knowledge based on high-standards research and provide research based education to build a more sustainable, smarter, and more humane world. The University of Oulu community has about 17,000 people in total. Our northern scientific community operates globally and creates conditions for the emergence of innovations.
We are now looking for a
Doctoral Researcher
to the education pilot in precision cancer medicine (iCANDOC)to join our Breast Cancer Genetics team inBiocenter Ouluand Translational Medicine Research Unit, Faculty of Medicine, at the University of Oulu.TheFaculty of Medicine, an integral part of the Kontinkangas Life Sciences Campus, is situated next to the University Hospital of Oulu. The campus is a unique combination of partners in research, education, health services and business.
About the job
A Doctoral Researcher position is available in the Breast Cancer Genetics teamlead by Professor Katri Pylkäs. The team aims to elucidate genetic risk factors for breast cancer, and to resolve the molecular mechanisms leading to breast cancer predisposition and subsequent malignant conversion. In this Doctoral Researcher project the focus is on deciphering genetic landscape of breast tumors through optical genome mapping and exome sequencing.The research will be conducted at the Translational Medicine Research Unit, Faculty of Medicine, and Biocenter Oulu. We have excellent molecular biology laboratories and instrumentation concerning the project’s needs. The Doctoral Researcher will join the University of Oulu Graduate School (UniOGS), which provides the framework and conditions for high-quality, research-driven doctoral training.
What we offer?
An exiting research project utilizing the state-of-the art genomic methods
The support of an experienced and enthusiastic research team where you can share your expertise and grow as an expert.
We have a HR Excellence in Research -quality label which is a recognition awarded by the European Commission for the development of researchers’ working conditions and careers.
Finland is one of the most livable countries in the world, with a high quality of life, safety, excellent education system, and competitive economy. Read more about living in Oulu.
Who are you?
You are the person we are looking for if you have:
Master’s degree in genetics, molecular genetics or bioinformatics or equivalent (the degree needs be completed before the starting date)
High motivation and the ability to work efficiently both independently and as part of a team
Solid background knowledge in genetics and genomics
Experience in conducting molecular geneticslaboratory work
Previous experience in genomic data analysis (exome-sequencing and/or optical genome mapping) is considered an advantage
Salary
Doctoral researchers selected in the pilot programme will by default be offered a three-year (36 month) fixed-term full-time employment contract by University of Oulu. These positions are available for highly motivated and talented researchers wishing to undertake and complete training for a research-focused doctoral degree, starting 1.1.2025 at the earliest. The selected applicants are expected to start their project no later than 1.2.2025. A six-month trial period is applied in the position.
The salary of the selected doctoral researchers will be paid monthly. The salary will be based on the levels 2-4 of the demand level chart for teaching and research staff of Finnish universities. In addition, a salary component based on personal work performance will be paid (maximum of 50 % of the job-specific component). Starting gross salary will be approx. 2500-2800 € per month (before taxes).
How to apply?
Applications, together with all relevant enclosures, should be submitted using the electronic application form by 15.10.2024 (23:59 Finnish local time). The application should be written in English and include the following:
A motivation letter (max. 2 pages) summarizing applicant’s professional experience and expertise and describing why the applicant is a good fit for this position. Also, information on personal research interests, experience and career plans are valuable to provide here.
Curriculum vitae (max. 2 pages). A recommended CV template can be found on the Finnish National Board on Research Integrity.
Certificates/Diplomas Scanned copy of the original relevant master’s degree certificates and transcript of records and, when necessary, official translations to Finnish or English.
Only applications containing all relevant appendices and submitted through the online recruitment system will be considered. Applications received after the call deadline will not be considered.
We welcome applicants from all backgrounds, including people of different ages, genders, and linguistic, cultural, or minority groups.
Contact Information
For further information, please contact Professor Katri Pylkäs (katri.pylkas(at)oulu.fi)
The University of Oulu is a multidisciplinary, international research university, with about 3,600 employees who produce new knowledge based on high-standards research and provide research based education to build a more sustainable, smarter, and more humane world. The University of Oulu community has about 17,000 people in total. Our northern scientific community operates globally and creates conditions for the emergence of innovations.
We are now looking for a
Doctoral Researcher
to the education pilot in precision cancer medicine (iCANDOC)to join our Colorectal Cancer Research Group in Translational Medicine Research Unit at the Faculty of Medicine of University of Oulu.
The Faculty of Medicine, an integral part of the Kontinkangas Life Sciences Campus, is situated next to Oulu University Hospital and is a unique combination of partners in research, education, health services, and business.
About the job
Colorectal cancer, the third most common cancer, is a highly heterogeneous disease at both molecular and morphological levels. Its progression is shaped by complex interactions between tumor cells and the surrounding stromal and immune cells. Our research group focuses on three key areas: (1) identifying the factors that drive colorectal cancer heterogeneity, (2) uncovering the role of tumor-host interactions in disease progression, and (3) developing novel biomarkers to advance precision medicine.
As a doctoral researcher in our group, you will participate in the analysis of large colorectal cancer cohorts. You will apply techniques such as multiplex immunohistochemistry, in situ hybridization, spatial transcriptomics to uncover the molecular variations that drive tumor phenotypes in colorectal cancer. You will apply data analysis methods and bioinformatics analyses to analyze large-scale molecular data. The findings of the project could refine future tumor classification systems, aid in developing novel biomarkers, and enable more personalized treatment approaches.
The doctoral training will give you a strong background for future tissue-based research related to cancer biology, tumor immunology, and bioinformatics. It will offer rich opportunities for networking, mobility, and further career development after completing the PhD in three years.
What we offer?
The support of an experienced and enthusiastic research team.
A dynamic research environment which promotes personal and professional growth as a scientist.
Possibility to gain expertise in cutting-edge tissue analysis methods such as multiplex immunohistochemistry and in situ hybridization, as well as sequencing-based molecular pathological methods.
We have a HR Excellence in Research -quality label which is a recognition awarded by the European Commission for the development of researchers’ working conditions and careers.
Finland is one of the most livable countries in the world, with a high quality of life, safety, excellent education system, and competitive economy. Read more about living in Oulu.
Who are you?
In order to succeed and enjoy the position, we expect from you:
Master’s or equivalent degree (e.g. licentiate) in biochemistry, biomedicine, bioinformatics, cell biology, data analysis, genetics, medicine, molecular biology, molecular genetics, or related fields
Strong motivation to learn and apply new research methods relevant to the project
Excellent communication and teamwork skills
Fluent in written and spoken English
We also appreciate
Previous experience in bioinformatics analyses and/or tissue/molecular analysis methods is considered an advantage
Doctoral researchers selected in the pilot programme will by default be offered a three-year (36 month) fixed-term full-time employment contract by University of Oulu. These positions are available for highly motivated and talented researchers wishing to undertake and complete training for a research-focused doctoral degree, starting January 1, 2025 at the earliest. The selected applicants are expected to start their project no later than February 1, 2025. A six-month trial period is applied in the position.
The salary will be based on the levels 2-4 of the demand level chart for teaching and research staff of Finnish universities. In addition, a salary component based on personal work performance will be paid (maximum of 50 % of the job-specific component). Starting gross salary will be approx. 2500-2800 € per month (before taxes).
How to apply?
Interested? If yes, please apply by 23.10.2024 (23:59 Finnish local time) through our recruitment system.
The application should be written in English and include the following:
A motivation letter (max. 2 pages) summarizing your professional experience and expertise and describing why you are a good fit for this position. Also, information on personal research interests, experience and career plans are valuable to provide here.
Certificates/Diplomas Scanned copy of the original relevant master’s degree certificates and transcript of records and, when necessary, official translations to Finnish or English.
Only applications containing all relevant appendices and submitted through the online recruitment system will be considered. Applications received after the call deadline will not be considered.
We welcome applicants from all backgrounds, such as people of different ages, genders and lingual, cultural or minority groups.
Contact Information
If you have any further questions, please contact Juha Väyrynen (juha.vayrynen(at)oulu.fi).
The University of Oulu is a multidisciplinary, international research university, with about 3,600 employees who produce new knowledge based on high-standards research and provide research based education to build a more sustainable, smarter, and more humane world. The University of Oulu community has about 17,000 people in total. Our northern scientific community operates globally and creates conditions for the emergence of innovations.
We are now looking for a
Doctoral Researcher
to the education pilot in precision cancer medicine (iCANDOC)to join our Lung Cancer team at the research unit of Translational Medicine, University of Oulu. University of Oulu, an integral part of the Kontinkangas Life Sciences Campus, is situated next to theFaculty of Medicine. The campus is a unique combination of partners in research, education, health services and business.
About the job
A Doctoral Researcher position is available in the Lung Cancer teamlead by Professor Jussi Koivunen. The team aims to elucidate lung cancer predisposition, prevention, early detection, and treatment. This Doctoral Researcher project the focus is on 1) genetic landscape of lung cancer (FINNGEN), and 2) lung cancer prevention and early detection using prospectively collected blood (LDCT-SC-FI) and tumor samples (iCAN).The research will be conducted at the Oulu University Hospital and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu. We have excellent molecular biology laboratories and instrumentation concerning the project’s needs. The Doctoral Researcher will join the University of Oulu Graduate School (UniOGS), which provides the framework and conditions for high-quality, research-driven doctoral training.
What we offer?
An exiting research project utilizing the state-of-the art biocomputing and biomolecular methods.
The support of an experienced and enthusiastic research team where you can share your expertise and grow as an expert.
We have a HR Excellence in Research -quality label which is a recognition awarded by the European Commission for the development of researchers’ working conditions and careers.
Finland is one of the most livable countries in the world, with a high quality of life, safety, excellent education system, and competitive economy. Read more about living in Oulu.
Who are you?
You are the person we are looking for if you have:
Licenciate of Medicine, or Master’s degree in Biochemistry, Bioinformatics or equivalent (the degree needs be completed before the starting date)
High motivation and the ability to work efficiently both independently and as part of a team
Solid background knowledge in pre-clinical or translational cancer research
Experience in conducting molecular biologylaboratory work
Doctoral researcher selected in the pilot programme will by default be offered a three-year (36 month) fixed-term full-time employment contract by University of Oulu. These positions are available for highly motivated and talented researchers wishing to undertake and complete training for a research-focused doctoral degree, starting 1.1.2025 at the earliest. The selected applicants are expected to start their project no later than 1.2.2025. A six-month trial period is applied in the position.
The salary of the selected doctoral researchers will be paid monthly. The salary will be based on the levels 2-4 of the demand level chart for teaching and research staff of Finnish universities. In addition, a salary component based on personal work performance will be paid (maximum of 50 % of the job-specific component). Starting gross salary will be approx. 2500-2800 € per month (before taxes).
How to apply?
Applications, together with all relevant enclosures, should be submitted using the electronic application form by 23.10.2024 (23:59 Finnish local time). The application should be written in English and include the following:
A motivation letter (max. 2 pages) summarizing applicant’s professional experience and expertise and describing why the applicant is a good fit for this position. Also, information on personal research interests, experience and career plans are valuable to provide here.
Certificates/Diplomas Scanned copy of the original relevant master’s degree certificates and transcript of records and, when necessary, official translations to Finnish or English.
Only applications containing all relevant appendices and submitted through the online recruitment system will be considered. Applications received after the call deadline will not be considered.
We welcome applicants from all backgrounds, including people of different ages, genders, and linguistic, cultural, or minority groups.
Contact Information
For further information, please contact Professor Jussi Koivunen (jussi.koivunen(at)oulu.fi)
The Human Brown Fat Metabolism Research Group at the Turku PET Centre is seeking a fixed-term Doctoral Researcher. The research focuses on investigating the role of signalling molecules that may influence the metabolism of brown fat in health and metabolic diseases. The chosen candidate will play a pivotal role in conducting translational and clinical research studies using advanced medical imaging methods. The selected candidate will have the opportunity to explore personal research ideas, engage in other compelling side projects, undertake international research visits, and benefit from access to unique datasets, providing excellent prospects for advancing their research career.
The position is fixed-term, starting as soon as possible or based on mutual agreement. Initially, the contract will be offered for one year with the strong possibility of an extension for an additional year. The doctoral researcher will be encouraged to seek funding from the graduate school and funding agencies.
The suitable candidate has the following:
Licentiate in medicine, or Master’s degree in biomedicine, biomedical imaging, biochemistry, drug development, or a closely related field;
Excellent communication, interpersonal and English language skills;
Ability to work independently and in a team;
In addition, the following will be considered an advantage:
Experience working in a clinical environment
Experience with in-vitro adipocyte cell cultures
Finnish language skills
The qualification requirements for the position of a Doctoral Researcher are stated in the Rules of Procedure of the University of Turku: https://www.utu.fi/en/university/organisation
In addition, when acquiring a doctoral degree, doctoral researchers are required to have demonstrated the ability and motivation to undertake postgraduate studies and the capacity to complete a doctoral degree in accordance with the research plan.
The salary is determined in accordance with the university salary system for teaching and research personnel. For a doctoral researcher, the salary will be in the beginning of the employment around 2400-2600 euros/month, when working full-time. The amount of the salary is defined when the employment contract is prepared and is influenced by previous experience and skills.
A six (6) month trial period applies to the position.
Applications must be submitted at the latest on October 7, 2024 (16:00) using the electronic application form of the University of Turku.
Please include with your application (One-PDF file):
CV (max 2 pages), including a list of publications
Contact information of two persons who are willing to provide a reference letter by separate request
degree certificates with translation in English or Finnish (if applicable)
study transcript
motivation letter
other documents that may influence the filling of the position
Apply between 21 August 2024 and 7 October 2024 16:00 (Europe/Helsinki)
Turku PET Centre
The National PET Centre is a joint institution of University of Turku, Åbo Akademi University and Turku University hospital, which is concentrated in research of positron emission tomography and offers imaging services for example to academic research, clinical diagnostics, and drug development.
The University of Turku is an inspiring and international academic community of 25,000 students and staff in Southwest Finland. We build a sustainable future with multidisciplinary research, education, and collaboration. With us, your work will have a significant impact and relevance in the changing world.
Are you interested in shaping the future of food by producing new sustainable food ingredients with cutting edge technology and with superb colleagues who are top experts in their field? Onego Bio might be just the place for you.
Onego Bio is a Finnish leading food-biotech company producing animal-free egg protein with precision fermentation. The company’s award-winning technology has placed them at the forefront of the industry, having cracked the code to producing bioidentical egg proteins that provide the same taste, functionality, and nutrition but without the poor efficiency and harmful impacts of animal agriculture. Onego Bio is launching its first product Bioalbumen® as an ingredient for the food industry and transforming the food system to meet the urgent sustainability requirements of the world. The company is focused on scaling precision fermentation to industrial scale with the superior Trichoderma reesei production platform.
Founded by alternative protein pioneer Maija Itkonen (CEO) and precision fermentation trailblazer Christopher Landowski (CTO), Onego Bio is a spin-off that salutes the remarkable work done by VTT Technical Research Centre of Finland for the next level cellular agriculture products and applications. In April 2024 Onego raised a $40M Series A funding round (one of the largest in the Nordics) for fueling scale up and go-to-market in the US. Since launching, the company has received massive international recognition, including being selected as a winner of Fast Company’s 2023 World Changing Ideas Awards. Onego Bio is a founding member of Food Fermentation Europe and Precision Fermentation Alliance US. Get to know us better by exploring our webpage www.onego.bio/about-us
We are now looking for a Senior Scientist to join our R&D team in Helsinki
In this position, you will play an essential role in developing, planning, and carrying out research projects with a project team and contribute towards our greater goal of providing animal free egg protein ingredients to the world. Ultimately, we aim to be part of building a sustainable food system with the help of our partners throughout the world. Towards this goal our R&D team will create microbial production systems for expressing egg white proteins using filamentous fungi.
Your responsibilities as Senior Scientist:
Scientific project work in protein production with filamentous fungi.
Using your expertise in molecular biology and strain engineering to create excellent fungal production strains for egg white proteins.
Developing strain screening technologies and workflows for filamentous fungi.
Further developing our fungal expression platforms using the newest innovations.
Project team management.
Working with our bioprocess team to improve the strains and bioprocess conditions.
Who we are looking for:
Proven, excellent laboratory skills and experience in molecular biology techniques such as DNA cloning, genome engineering, protein and possibly genome analysis.
MSc or PhD in biotechnology, molecular biology, fungal biology, or related field.
Four or more years of experience working with filamentous fungi.
Good written and spoken English skills.
Proven ability to effectively instruct other scientists or technical staff.
An innovative person who exhibits effective leadership skills and has experience leading others.
Someone with deep knowledge in the fields of fungal biology and strain engineering.
Skills in Bioinformatics are considered as a big plus as well as experience in working in an industrial biotechnology company.
As a person, we hope that you:
Independently plan your work and perform experiments skilfully and precisely.
Self-motivated and willing to take the initiative to get projects accomplished.
Have strong communication and collaboration skills.
Work well with other team members and contribute to a good working environment.
Can tolerate pressure and maintain a good work-life balance.
Are flexible to take on a variety of tasks anticipated in a start-up company.
With Onego Bio, you’ll enjoy:
Molecular biology with an impact. Onego Bio works on creating cutting-edge microbial protein production systems. Microbial production technology to produce egg white protein shows potential to significantly mitigate environmental impacts up to 90% according to recent study published in Nature Food. The positive impact of our technology does not only contribute positively on the environment but also supply chain stability, global health, food security and animal welfare. Egg is one of the world’s most popular proteins and our team stands to meet the demand in a way that preserves the future of our planet.
Superb colleagues. We offer working in a passionate environment within a fun and diverse team who want to make an impact in the world. With Onego Bio, you will join a dedicated group of top experts in their respective fields who foster a culture of trust, openness, and sharing ideas.
Competitive salary. We want to attract the best people, so we will provide competitive salaries.
Nordic work–life balance. Working in Finland, the happiest country in the world, enables a high quality of life. At Onego Bio, we make our people’s well-being a priority. We offer 6 weeks paid vacation a year, among other benefits including extended occupational healthcare, and exercise and culture benefits.
Apply now and join our community of brilliant minds!
Please send your CV and application letter as soon as possible but at the latest by 30th of September 2024. We will process applications as they come in and fill the position as soon as we find the right candidate.
The Antibody-Drug Conjugates Research Team is seeking a talented and highly motivated in vivo pharmacology Research Scientist/Senior Scientist. The successful candidate will possess a PhD or MSc and extensive hands-on in vivo work experience in academic or industry settings. We are looking for someone with a proven track record of planning and executing in vivo studies, excellent teamwork skills, and a profound understanding of cancer biology. The chosen candidate will have the opportunity to work collaboratively with a diverse team of researchers and assistants to drive the advancement of groundbreaking Antibody-Drug Conjugates (ADCs) from the conceptual stage to the clinical candidate phase. This role provides an exciting opportunity to apply expertise in cancer research and contribute to the development of potentially life-saving therapies.
Key responsibilities
Independently design, perform/coordinate, and analyze results of efficacy and PK/PD in vivo studies aimed at the discovery of antibody-drug conjugates.
Develop and optimize experimental protocols and methodologies.
Build strong partnerships with key stakeholders to understand scientific challenges and project needs, and actively facilitate the execution of in vivo studies.
Support in-vivo needs across the Oncology research organization.
Present research findings to project teams and management and prepare technical reports.
Work with external academic, biotechnology, and contract research organizations to advance our projects.
Commit to scientific rigor, high data quality, and careful documentation.
This permanent position is located in Turku, Finland, and reports directly to the Head of the Antibody-Drug Conjugates Team.
Description of unit
The Antibody-Drug Conjugates Team is one of three scientific units in Oncology Research, a part of Orion’s RnD Organization. The team is focused on discovering therapeutic targets and actively developing ADCs by utilizing a broad panel of biophysical, biochemical, cellular, and in vivo methods. We aim to develop cutting-edge ADC therapies that can transform cancer patients’ lives.
We offer
We offer the opportunity to work alongside talented and experienced scientists and assistants across Orion’s R&D, where you’ll be part of an exciting pipeline in an enthusiastic working environment that allows you to leverage your strengths to enhance your competence and build your career. You’ll also have the unique chance to innovate and contribute to future therapies for patients. Our excellent working atmosphere is built on mutual trust, continuous development, and a strong appreciation of colleagues. Please visit our website to find further information about Orion as an employer https://www.orion.fi/en/careers/orion-as-an-employer/.
Requirements
To be successful in this role, the candidate must have the demonstrated knowledge, skills, and abilities in the following:
MSc/PhD in cancer biology, pharmacology, or relevant with at least 4 years of hands-on in vivo work experience in academic or industry settings.
Authorized competencies to work with laboratory animals.
Demonstrated hands-on experience in planning and executing in vivo pharmacology studies, including diverse mouse models and routes of drug administration, monitoring techniques, and sample collection.
Strong knowledge of tumor biology, supported by a publication record.
Understanding of pharmacology and PK/PD principles.
Good understanding of the Animals (Scientific Procedures) Act.
Ability to work independently and collaboratively within multidisciplinary research teams, and experience in coordinating research assistant work.
Excellent problem-solving, critical thinking, communication, and presentation skills.
Highly organized with documentation of experimental plans, timelines, and reports.
Additional information
Are you interested in this opportunity? Please send your application with the latest CV, cover letter, and salary request in English by September 18th, 2024. We will start reviewing applications during the application period.
For additional details, do not hesitate to contact Dr Marcin Chrusciel, Head of Antibody Drug Conjugates Team tel. +358 509667861 on any of the following times (Finnish Time): 6th of September 15:00-16:00 and 13th of September 15:00-16:00.
#LI-ORION
Approved medical examination which also includes drug testing is required prior to the employment. We will also carry out a security clearance prior to the employment for the selected person.
Orion Corporation operates in more than 30 countries, where we Orionees, 3600 in total, work in all kinds of positions. Among us there are Research Scientists, Laboratory Technicians, Engineers and IT Specialists as well as people working in Production, just to mention some examples. We offer diverse and responsible jobs to our personnel in a truly multi-disciplinary work environment. We encourage people to develop their competences and offer opportunities to affect the job description and creating their own career path at Orion. We are searching for top talents who are ready to share our passion for the work that we do.
Sinulla on vastuu mikrobiologian osastostamme ja sen kehityksestä, analyysitulosten raportoimisesta ja asiakaspalvelusta. Yhdessä asiakkaidemme kanssa selvität ja rakennat heidän haasteisiinsa sopivat testauskokonaisuudet ja kehität mikrobiologian osastomme toimintaa. Yhteistyössä viranomaisten kanssa pysyttelet ajanhermolla muuttuvista testausvaatimuksista ja varmistat, että asiakkaillemme tarjoamat testauspalvelut täyttävät viranomaisten asettamat vaatimukset.
Mikrobiologian laboranttiemme lähiesimiehenä tuet tiimisi hyvää työilmapiiriä ja varmistat, että hommat sujuvat. Sinulla on käytännön kokemusta mikrobiologisista viljelymenetelmistä, laadunvarmistuksesta mikrobiologian laboratoriossa ja uusien analyysimenetelmien validoinnista.
Palvelulaboratoriomme haasteet ja monipuoliset tehtävät tarjoavat sinulle hyvän mahdollisuuden oman osaamisesi kehittämiseen.
Hakijalta edellytämme: -Tehtävään soveltuvaa koulutusta mikrobiologiasta, esim. ETM, MMM, FM -Ulospäin suuntautuneisuutta, oma-aloitteisuutta, päätöksentekokykyä ja hyvää tiimihenkeä
Katsomme eduksi elintarvikemikrobiologian osaamisen, kokemuksen uusien analyysimenetelmien validoinnista, työskentelyn akkreditoidussa testauslaboratoriossa, aiemman esimieskokemuksen ja IT-taidot (esim. LIMS, V2L).
Tarjoamme sinulle: -Haastavan ja monipuolisen työnkuvan -Merkityksellisen työn erilaisten mikrobiologisten analyysimenetelmien parissa -Viihtyisän työympäristön ja mukavat työkaverit -Joustavat työajat ja mahdollisuuden vaikuttaa omaan työhösi
Lisätietoja antaa toimitusjohtaja Aleksi Laine, p. 044 974 0127.
Lähetä hakemus ja CV palkkatoivomuksineen 30.9.2024 mennessä osoitteeseen aleksi.laine@kymlab.fi. Hakemuksia käsitellään jo hakuaikana, joten hae heti.
Jätä hakemus: https://tyomarkkinatori.fi/henkiloasiakkaat/avoimet-tyopaikat/8182cc9e-2… Yhteystiedot: Lähetä hakemus ja CV palkkatoivomuksineen 30.9.2024 mennessä osoitteeseen aleksi.laine@kymlab.fi. Hakemuksia käsitellään jo hakuaikana, joten hae heti. Työpaikan osoite: Patosillantie 2, 45700 Kuusankoski Työ alkaa: Työskentely alkaa mahdollisimman pian Työaika: Kokoaikatyö Työn kesto: Toistaiseksi voimassa oleva Hakuaika päättyy: 30.09.2024 20:59 Ilmoitus jätetty: 04.09.2024 15:51 Työmarkkinatorin ilmoitusnumero: 8182cc9e-2e02-499d-8077-ed8d9661c8f9